1 Magnificent Dividend Stock Down 30% to Buy and Hold Forever

Abbott Laboratories (NYSE: ABT) is presented as an attractive dividend stock despite a 30% drop in its share price over the past year. The article highlights the company’s opportunities for sales growth through acquisitions like Exact Sciences and its FreeStyle Libre continuous glucose monitoring devices. As a Dividend King with a 2.8% forward dividend yield, the stock is considered a potential bargain for long-term investors.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin